Many cancer-promoting proteins can hardly be inhibited. A new drug causes the cell to selectively decompose them. The principle should enable further cancer therapies.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Many cancer-promoting proteins can hardly be inhibited. A new drug causes the cell to selectively decompose them. The principle should enable further cancer therapies.